Investment: Investment Banking Latin America Citi

Cain Brothers investment Banking

Banking Investment / August 19, 2016

Cain Brothers, a pre-eminent investment bank focused exclusively on healthcare, has announced that Kristin Carey has joined the Firm as a Managing Director to lead the Firm’s coverage of the pharmaceutical outsourcing and specialty pharmaceutical industries.

Ms. Carey brings over 25 years of healthcare investment banking experience and expertise to the Cain Brothers team. She was previously a Senior Managing Director at Teneo Capital. Ms. Carey’s notable transactions include the recapitalization of Pharmaceutics International (Pii), the divestiture of certain business units of Aptuit by Welsh Carson Anderson & Stowe, the acquisition of Penn Pharmaceutical Services by Packaging Coordinators, and JLL Partners’ acquisition of BioClinica. Ms. Carey worked for eleven years as a Managing Director in JP Morgan’s healthcare investment banking group and previously at Hambrecht & Quist. She received a B.S. from the University of Virginia’s McIntire School of Commerce.

“Kristin brings exceptional experience to our team and will enable us to expand our successful franchise and more thoroughly address the growing pharmaceutical outsourcing sector, ” said Rob Fraiman, President & CEO of Cain Brothers. “We believe this is a natural extension to our strong healthcare services, life sciences and private equity sponsors coverage. Kristin is an outstanding addition to our expanding team of highly capable and respected bankers.”

“I am very excited to join the Cain Brothers team. I have long admired and respected their deep domain expertise within healthcare. I look forward to assisting in creating significant value for the Firm’s clients, ” said Ms. Carey. She added, “Pharmaceutical outsourcing companies are making tactical moves into broader healthcare services sectors. Cain Brothers has the breadth and depth of relationships to offer significant cross-pollination of ideas for clients.”